Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sishi, Tang"'
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Epithelioid Hemangioendothelioma (EHE) is an extremely rare malignancy originating from endothelial cells, with an incidence rate of less than 1/100,000. To date, there have been no documented cases of Diaphragm EHE in the English
Externí odkaz:
https://doaj.org/article/a5f1db0680114af9851d5dbd1dcbc003
Publikováno v:
Heliyon, Vol 10, Iss 14, Pp e34397- (2024)
Multiple myeloma (MM) is an incurable malignancy of plasma cells that is sensitive to T-5224, an AP-1 inhibitor. Previous study indicated that T-5224 inhibits proliferation and induces apoptosis in MM cells. However, the high mortality cannot be full
Externí odkaz:
https://doaj.org/article/2658865f309e4fb380e80bea3006e859
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 7, Pp 2699-2700 (2023)
Externí odkaz:
https://doaj.org/article/7bb796dd028e4aa0a4ae2e1e6c8a54e7
Autor:
Yuanxin, Ye, Yanhong, Zhou, Qin, Zheng, Sishi, Tang, Yang, Dai, Yi, Zhou, Minjin, Wang, Juan, Zhou, Xiaojun, Lu, Lanlan, Wang, Binwu, Ying
Publikováno v:
In Leukemia Research April 2019 79:6-16
Publikováno v:
ACS Sustainable Chemistry & Engineering. 11:3568-3575
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f062760bb5ebef828cc5b4e65700ced
https://doi.org/10.1021/acssuschemeng.2c05045
https://doi.org/10.1021/acssuschemeng.2c05045
Autor:
Fangrong Zhang, Qin Yang, Sishi Tang, SiYi Jiang, Qiangqiang Zhao, Jian Li, Cong Xu, Jing Liu, Yunfeng Fu
Background: Multiple myeloma (MM) is a malignant and incurable disease. Currently, chemotherapy is the primary approach for the treatment of MM. Bortezomib (BTZ) is a breakthrough drug for MM, significantly improving patient survival. However, BTZ ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47f6a7bbd9e0190647a17720f9fd4763
https://doi.org/10.21203/rs.3.rs-2532590/v1
https://doi.org/10.21203/rs.3.rs-2532590/v1
Autor:
Danna Wei, Sishi Tang, Nana Zhe, Qin Fang, Tingting Lu, Jishi Wang, Bingqing Cheng, Dan Ma, Zheng Zhou, Kunlin Yu
Publikováno v:
Biomedicine & Pharmacotherapy. 100:509-520
To improve the treatment outcomes of acute myeloid leukemia (AML), epigenetic modification has been widely tested and used in recent years. However, drug-resistance is still a choke point to cure the malignancy. The growth factor independent 1 transc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b38e084f758808948c55c0834884c7a
https://doi.org/10.1016/j.biopha.2018.02.039
https://doi.org/10.1016/j.biopha.2018.02.039
Autor:
Kunling Yu, Sishi Tang, Jishi Wang, Xingyi Kuang, Weili Wang, Bo Hu, Bingqing Cheng, Qing Fang, Dan Ma
Publikováno v:
Experimental Cell Research. 363:196-207
Inhibition of histone deacetylase (HDAC) is a promising therapeutic strategy for various hematologic cancers. Panobinostat has been approved for treating patients with multiple myeloma (MM) by the FDA. Since the mechanism for the resistance of panobi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a11cc375a49c87970a59cac074c74e2
https://doi.org/10.1016/j.yexcr.2018.01.005
https://doi.org/10.1016/j.yexcr.2018.01.005
Autor:
Jishi Wang, Sishi Tang, Xinyao Li, Weibing Wu, Bingqing Cheng, Dan Ma, Jibing Xu, Yongling Guo, Nana Zhe
Publikováno v:
Anti-Cancer Drugs. 29:61-74
Multiple myeloma (MM) is a hematological malignancy that is characterized by the clonal expansion of plasma cells in the bone marrow. Histone deacetylases (HDACs) represent a new type of molecular targeted therapy for different types of cancers and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6162c9ea8001711c7941de0db38fceab
https://doi.org/10.1097/cad.0000000000000568
https://doi.org/10.1097/cad.0000000000000568
Autor:
Ping Liu, Sishi Tang, Dan Ma, Bingqing Cheng, Yudan Liao, Xiaojing Lin, Mei Ren, Xiuying Hu, Zhen Zhou, Jishi Wang, Tingting Lu, Nana Zhe, Peifan Li, Yaming Zhang, Qin Fang
Publikováno v:
Oncotarget
// Zhen Zhou 1, 2, 3, 5 , Qin Fang 4, 5 , Dan Ma 1, 2, 3 , Nana Zhe 1, 2 , Mei Ren 1, 2 , Bingqing Cheng 1, 2 , Peifan Li 1, 2 , Ping Liu 1, 2 , Xiaojing Lin 1, 2 , Sishi Tang 1, 2 , Xiuying Hu 1, 2 , Yudan Liao 1, 2 , Yaming Zhang 1, 2 , Tingting Lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d59504084d4992e993ced09133eff0bd
http://europepmc.org/articles/PMC5667976
http://europepmc.org/articles/PMC5667976